Vollenweider Peter
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Clin Chem Lab Med. 2003 Sep;41(9):1107-19. doi: 10.1515/CCLM.2003.173.
The incidence of type 2 diabetes mellitus (T2D) and obesity is increasing rapidly worldwide, reaching epidemic proportions. Insulin resistance is a key feature in both conditions and plays an important pathophysiological role. Over the last two decades a central role in the origin of insulin resistance has emerged for defects in the intracellular insulin signaling cascade leading to glucose uptake. Herein, we will 1) review insulin signaling pathways leading to glucose uptake, 2) review mouse models of insulin resistance that demonstrate the pathophysiologic importance of specific defects of these pathways and 3) discuss the molecular basis for insulin resistance in some human disease states known to be associated with insulin resistance. Finally, we will briefly mention some novel treatment targets for T2D stemming from this knowledge.
2型糖尿病(T2D)和肥胖症在全球范围内的发病率正在迅速上升,已达到流行程度。胰岛素抵抗是这两种病症的关键特征,并发挥着重要的病理生理作用。在过去二十年中,导致葡萄糖摄取的细胞内胰岛素信号级联缺陷在胰岛素抵抗的起源中发挥了核心作用。在此,我们将:1)回顾导致葡萄糖摄取的胰岛素信号通路;2)回顾胰岛素抵抗的小鼠模型,这些模型证明了这些通路特定缺陷的病理生理重要性;3)讨论一些已知与胰岛素抵抗相关的人类疾病状态中胰岛素抵抗的分子基础。最后,我们将简要提及基于这些知识的一些T2D新型治疗靶点。